Prognostic Significance of Apex Axillary Invasion for Locoregional Recurrence and Effect of Postmastectomy Radiotherapy on Overall Survival in Node-Positive Breast Cancer Patients

World Journal of Surgery

Volumn 28, Issue 3, 2004, Pages 236-241

  Kuru, Bekir ^a,b   Camlibel, Mithat ^a   Dinc, Soykan ^a   Gulcelik, Mehmet A ^a   Alagol, Haluk ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; LYMPH NODES; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1642301630     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7215-1     Document Type: Article

References (36)

1. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N. Engl. J. Med. 1997;337:949-955
2. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 1997;337:956-962
3. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000;355:1757-1770
4. Recht A, Bartelink H, Fourquet A, et al. Postmastectomy radiotherapy: questions for the twenty-first century. J. Clin. Oncol. 1998;16:2886-2889
5. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 2001;19:1539-1569
6. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J. Clin. Oncol. 1987;5:1546-1555
7. Overgaard M, Jensen M, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999;353:1641-1648
8. Harris J, Halpin-Murphy P, McNeese M, et al. Consensus statement of postmastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:989-990
9. Overgaard M. Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer. Eur. J. Cancer 2002;37:S33-S43
10. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N. Eng. J. Med. 1995;333:1444-1445
11. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J. Clin. Oncol. 2000;18:1220-1229
12. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on cancer staging system for breast cancer. J. Clin. Oncol. 2002;20:3628-3636
13. Smith JA, Araujo JG, Gallager HS, et al. Analysis of total lymph node involvement versus level of metastasis. Cancer 1977;39:527-532
14. Zurrida S, Morabito A, Galimberti V, et al. Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int. J. Oncol. 1999;15:475-480
15. Barth RJ, Danforth DN, Venzon DJ, et al. Level of axillary involvement by lymph-node metastases from breast cancer is not an independent predictor of survival. Arch. Surg. 1991;126:574-577
16. Canavese G, Catturich A, Vecchio C, et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur. J. Surg. Oncol. 1998;24:104-109
17. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 1978;41:1170-1178
18. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 1999;17:1689-1700
19. Muss HB, Coper MR, Brockschmidt JK, et al. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res. Treat. 1991;19:77-84
20. Wallgren A, Arner O, Bergström J, et al. Radiation therapy in operable breast cancer: results from the Stockholm trial on adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1986;12:533-537
21. Uematsu M, Bornstein BA, Recht A, et al. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage 1-3 breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993;25:765-770
22. Katz A, Strom EA, Bucholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J. Clin. Oncol. 2000;18:2817-2827
23. Stefanik D, Goldberg R, Byrne P, et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1985;3:660-665
24. Jager JJ, Volovics L, Schouten LJ, et al. Locoregional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother. Oncol. 1999;50:267-275
25. Rangan AM, Ahern V, Yip D, et al. Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy. Aust. N. Z. J. Surg. 2000;70:649-655
26. Fowble B, Gray R, Gilchrist K, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 1988;6:1107-1117
27. Rosenmann J, Bernard S, Kober C, et al. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-82). Cancer 1986;57:1421-1425
28. Timothy SKC, Teng S, Stolier AJ, et al. Postmastectomy radiation in patients with four or more positive nodes. Am. Surg. 2002;68:539-545
29. Fisher BJ, Perera FE, Cooke AL, et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int. J. Radiat. Oncol. Biol. Phys. 1997;38:541-550
30. Fisher BJ, Perera FE, Cooke AL, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 1997;38:551-559
31. Cheng JC, Chen C, Liu M, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:980-988
32. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993;72:778-782
33. Heteledikis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:31-34
34. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 1994;12:447-453
35. Diab SG, Hilsenbeck SG, Moor C, et al. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J. Clin. Oncol. 1998;16:1655-1660
36. Arriagada R, Rutqvist LE, Mattsson R, et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J. Clin. Oncol. 1995;13:2869-2878